...
【24h】

The Hypothalamus and Obesity

机译:下丘脑和肥胖

获取原文
获取原文并翻译 | 示例
           

摘要

Obesity has reached epidemic proportions across the developed world. Even though there have been numerous scientific advances in terms of the understanding of the regulation of energy homeostasis, few novel anti-obesity drugs have emerged. Furthermore, those that are available have limited efficacy in producing and maintaining a weight loss beyond 10%. This is partly attributable to the complex neuronal circuitry at play within the central nervous system and periphery, which acts to regulate food intake and energy expenditure. This article will focus on a selection of the many products (peptides, neurotransmitters and others) such as endocannabinoids, Neuropeptide Y, Orexins, Melanin- Concentrating Hormone, Melanocortins, Cocaine and Amphetamine Regulated Transcript and Serotonin, expressed within the brain, that have been shown to influence energy balance. The true relevance of many of these to the regulation of human energy balance remains uncertain, but some novel anti-obesity drugs aimed at these targets are likely to emerge in the next few years.
机译:肥胖在发达国家已达到流行病的程度。尽管在能量稳态调节方面有许多科学进展,但很少出现新型抗肥胖药。此外,可用的那些在产生和保持体重减轻超过10%方面的功效有限。这部分归因于中枢神经系统和周围神经系统中复杂的神经元回路在起作用,从而调节食物的摄入和能量消耗。本文将重点介绍已在大脑内表达的许多产品(肽,神经递质和其他产品)的选择,例如内源性大麻素,神经肽Y,食欲素,黑色素浓缩激素,黑皮质素,可卡因和苯丙胺调节的转录物和5-羟色胺。被证明会影响能量平衡。其中许多与调节人体能量平衡的真正相关性尚不确定,但一些针对这些目标的新型抗肥胖药可能会在未来几年出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号